Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1985;72:1365-1371

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Molloy, W. D.
Right arrow Articles by Prewitt, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Molloy, W. D.
Right arrow Articles by Prewitt, R. M.

Circulation, Vol 72, 1365-1371, Copyright © 1985 by American Heart Association


ARTICLES

Treatment of canine permeability pulmonary edema: short-term effects of dobutamine, furosemide, and hydralazine

WD Molloy, KY Lee, L Girling and RM Prewitt

The effects of treatment of oleic acid pulmonary edema with dobutamine, furosemide, and hydralazine on cardiopulmonary function in 24 dogs were investigated. Pulmonary capillary wedge pressure (PCWP) was adjusted to approximately 7 mm Hg; 45 min after oleic acid (0.08 ml/kg), dogs were randomly divided into a control group, in which PCWP was maintained at approximately 7 mm Hg, and into treatment groups as described above. Mean time-averaged PCWP was 2.3 mm Hg in dogs treated with dobutamine, 4.1 mm Hg with furosemide, and 4.4 mm Hg with hydralazine. Four hours of treatment with dobutamine and furosemide significantly (p less than .01) reduced accumulation of lung water compared with the control and hydralazine groups. Qs/Qt was lower (p less than .05) with dobutamine and furosemide compared with the other groups. In dogs given hydralazine, cardiac output (CO) and systemic vascular resistance (SVR) remained constant over the 4 hr treatment interval. In contrast, in all other groups, SVR increased and CO decreased (both p less than .05). The short-term pulmonary effects of the above drugs are probably explained by differences in PCWP and/or by regional pulmonary vascular effects.


This article has been cited by other articles:


Home page
NEJMHome page
The National Heart, Lung, and Blood Institute Acut
Comparison of Two Fluid-Management Strategies in Acute Lung Injury
N. Engl. J. Med., June 15, 2006; 354(24): 2564 - 2575.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
F. A. TIBAYAN, A. N. CHESNUTT, H. G. FOLKESSON, J. EANDI, and M. A. MATTHAY
Dobutamine Increases Alveolar Liquid Clearance in Ventilated Rats by Beta-2 Receptor Stimulation
Am. J. Respir. Crit. Care Med., July 1, 1997; 156(2): 438 - 444.
[Abstract] [Full Text]


Home page
J Intensive Care MedHome page
V. Courtney Broaddus, Y. Berthiaume, J. W. Biondi, and M. A. Matthay
Analytic Reviews : Hemodynamic Management of the Adult Respiratory Distress Syndrome
J Intensive Care Med, August 1, 1987; 2(4): 190 - 213.
[Abstract] [PDF]